Targets and self management for the control of blood pressure in stroke and other at-risk groups (TASMIN-SR): a randomised controlled trial

ISRCTN ISRCTN87171227
DOI https://doi.org/10.1186/ISRCTN87171227
Secondary identifying numbers 9361
Submission date
14/12/2010
Registration date
14/12/2010
Last edited
27/08/2014
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Claire Schwartz
Scientific

Primary Care Clinical Sciences
School of Health and Population Sciences
Edgbaston
Birmingham
B15 2TT
United Kingdom

Email c.l.schwartz@bham.ac.uk

Study information

Study designMulticentre randomised interventional treatment trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)GP practice
Study typeTreatment
Scientific title
Study acronymTASMIN-SR
Study objectivesTASMIN-SR is a primary-care based, unblinded, randomised controlled trial of self-management of blood pressure consisting of self-monitoring with self-titration of anti-hypertensive medication in people with stroke and other at-risk conditions.

Recruitment will be through the Primary Care Research Network, with patients invited to participate if they have a diagnosis of stroke/transient ischaemic attack (TIA), diabetes, chronic kidney disease (CKD3), coronary artery bypass graft (CABG), myocardial infarction (MI) or angina, and their blood pressure is above 130/80 mmHg. Patients will be randomised to either self-management of blood pressure or usual care.

The main research questions are:
1. Does self-management of blood pressure (BP) result in better control of BP in people with Stroke and other at-risk conditions compared to usual care?
2. Is self-management of BP in people with Stroke and other at-risk conditions acheivable in routine practice and is it acceptable to patients?
3. What is the relationship between self-management of BP, self-efficacy, lifestyle behaviours, patient attitudes to health and health care and use of other self-care strategies in people with Stroke and other at-risk conditions?
4. Is self-management of BP in people with Stroke and other at-risk conditions cost effective?

Please note that as of 04/02/2013, the anticipated end date for this study was updated from 31/08/2011 to 31/07/2013.
Ethics approval(s)MREC approved, 30/09/2010, ref: 10/H1013/60
Health condition(s) or problem(s) studiedTopic: Primary Care Research Network for England, Cardiovascular; Subtopic: Not Assigned, Cardiovascular (all Subtopics); Disease: Cardiovascular, All Diseases
InterventionSelf management of BP:
Patients will monitor their own blood pressure at home each month, and follow a pre-determined titration plan if their BP is above target over two consecutive months.

Follow-up length: 12 months
Study entry: single randomisation only
Intervention typeOther
Primary outcome measureSystolic blood pressure, measured at baseline, 6 months and 12 months
Secondary outcome measures1. Adverse events, measured at baseline, 6 months and 12 months
2. Anxiety, measured at baseline, 6 months and 12 months
3. Attitudes to health and health care, measured at baseline, 6 months and 12 months
4. Blood pressure measurement preference, measured at baseline, 6 months and 12 months
5. Diastolic Blood pressure, measured at baseline, 6 months and 12 months
6. Health related quality of life, measured at baseline, 6 months and 12 months
7. Lifestyle behaviours, measured monthly
8. Pulse rate, measured at baseline, 6 months and 12 months
9. Reasons for non-participation, measured at invitation/baseline
10. Self-care strategies, measured at baseline, 6 months and 12 months
11. Self-management self-efficacy, measured monthly
12. Time at target blood pressure, measured at baseline, 6 months and 12 months
Overall study start date01/12/2010
Completion date31/07/2013

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participantsPlanned sample size: 540; UK sample size: 540
Key inclusion criteria1. Aged above 35 years, either sex
2. Have had a diagnosis of stroke/TIA, diabetes, CKD3, MI, angina, or CABG
3. Systolic blood pressure greater than 130/80 mmHg
Key exclusion criteria1. Inability to self-monitor such as dementia or score over 10 on the short orientation memory concentration test (and with no carer support)
2. Postural hypotension (fall in SBP greater than 20 mmHg after 1 minute standing)
3. Taking more than three anti-hypertensive medications
4. Taking part in a current blood pressure study or previously taken part in TASMINH2
5. Terminal disease
5. Pregnant
6. Blood pressure not managed by the GP and acute cardiovascular event in the last 3 months
Date of first enrolment01/12/2010
Date of final enrolment31/07/2013

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Primary Care Clinical Sciences
Birmingham
B15 2TT
United Kingdom

Sponsor information

University of Birmingham (UK)
University/education

Department of Primary Care and General Practice
Primary Care Clinical Sciences Building
Edgbaston
Birmingham
B15 2TT
England
United Kingdom

Website http://www.birmingham.ac.uk/index.aspx
ROR logo "ROR" https://ror.org/03angcq70

Funders

Funder type

Government

National Institute for Health Research (NIHR) (UK) - Programme Grant for Applied Research (PGfAR) (ref: RP-PG-0606-1153)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Protocol article protocol 23/03/2013 Yes No
Results article results 27/08/2014 Yes No